CPO
AZN icon

Cerity Partners OCIO’s AstraZeneca AZN Stock Holding History

Cerity Partners OCIO’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$492K Buy
3,631
+94
+3% +$11.8K 0.02% 314
2022
Q3 		$388K Buy
3,537
+150
+4% +$19K 0.01% 338
2022
Q2 		$448K Buy
+3,387
New +$444K 0.01% 316

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerity Partners OCIO's AZN Position: Q4 2022 in Review

Cerity Partners OCIO increased its AstraZeneca (AZN) stake by 2.7% in Q4 2022, buying an estimated $11.8K and bringing the position to 3,631 shares worth $492K. The position accounts for 0.02% of the portfolio, ranked #314.

Cerity Partners OCIO first reported a position in AZN in Q2 2022 and has held it in 3 quarters since. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Cerity Partners OCIO held 3,631 shares of AstraZeneca worth $492K as of Q4 2022.
  • Cerity Partners OCIO bought 94 AstraZeneca shares in Q4 2022, an estimated $11.8K.
  • AstraZeneca made up 0.02% of Cerity Partners OCIO's portfolio in Q4 2022, its #314 holding.
  • Cerity Partners OCIO first reported a position in AstraZeneca in Q2 2022 and has held it in 3 quarters since.
  • 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.